Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients

BACKGROUND: Belatacept-based therapy in kidney transplant recipient has been shown to increase long-term renal allograft and patient survival compared with calcineurin inhibitor–based therapy, however, with an increased risk of acute T cell-mediated rejection (aTCMR). An improved understanding of co...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Zwan, Marieke, Baan, Carla C., Colvin, Robert B., Smith, Rex N., White, Rebecca A., Ndishabandi, Dorothy, Nigg, Alex L., van den Bosch, Thierry P.P., de Graav, Gretchen N., Clahsen-van Groningen, Marian C., Hesselink, Dennis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324913/
https://www.ncbi.nlm.nih.gov/pubmed/30656216
http://dx.doi.org/10.1097/TXD.0000000000000857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324913/
https://www.ncbi.nlm.nih.gov/pubmed/30656216
http://dx.doi.org/10.1097/TXD.0000000000000857

Ejemplares similares